• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AstraZeneca Says Bydureon Trial Meets Safety Objectives; No Significant CV Reduction

    AstraZeneca Says Bydureon Trial Meets Safety Objectives; No Significant CV Reduction

  2. Genomic Vision to Enter into Technological Collaboration with AstraZeneca in Oncology

    Genomic Vision to Enter into Technological Collaboration with AstraZeneca in Oncology

  3. AstraZeneca in Pact with Recordati for Heart-Drug Seloken in Europe

    AstraZeneca in Pact with Recordati for Heart-Drug Seloken in Europe

  4. Pieris Pharma stock soars 54% on news of $57.5 mln AstraZeneca deal

    Pieris Pharma stock soars 54% on news of $57.5 mln AstraZeneca deal

  5. UPDATE: FTSE 100 closes at an all-time high as AstraZeneca rallies, pound stalls

    UPDATE: FTSE 100 closes at an all-time high as AstraZeneca rallies, pound stalls

  6. LONDON MARKETS: FTSE 100 Closes At An All-time High As AstraZeneca Rallies, Pound Stalls

    LONDON MARKETS: FTSE 100 Closes At An All-time High As AstraZeneca Rallies, Pound Stalls

  7. AstraZeneca Imfinzi's Phase III Pacific Trial Positive; Plans Submission

    AstraZeneca Imfinzi's Phase III Pacific Trial Positive; Plans Submission

  8. FTSE 100 rises as AstraZeneca rallies and pound stalls

    FTSE 100 rises as AstraZeneca rallies and pound stalls

  9. LONDON MARKETS: FTSE 100 Rises As AstraZeneca Rallies And Pound Stalls

    LONDON MARKETS: FTSE 100 Rises As AstraZeneca Rallies And Pound Stalls

  10. AstraZeneca Asthma Drug Fails to Meet Primary Endpoint

    AstraZeneca Asthma Drug Fails to Meet Primary Endpoint

12345

©2017 Morningstar Advisor. All right reserved.